Menopause Flashcards

(36 cards)

1
Q

Definition of menopause

A

The final menstrual period, can only be diagnosed after 12 consecutive months of amenorrhoea while not on any hormonal treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Definition of perimenopause

A

The symptoms experienced in the years preceding menopause while ovarian activity fluctuates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Definition of surgical menopause

A

Menopause occurring when functional ovaries are surgically removed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Definition of premature menopause

A

Menopause occurring before the age of 45

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Average age of menopause in Western society

A

52 years (no change in last 150 years)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Iatrogenic causes of menopause

A

Surgical removal of functioning ovaries
Radiotherapy
Chemotherapy
Temporarily during GnRH analogue treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Causes of primary premature ovarian failure

A
Chromosome abnormalities (Turner's, Fragile X)
Autoimmune: hypothyroidism, Addison's, Myasthenia Gravis
Enzyme: galactosaemia, 17a-hydroxylase deficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Causes of secondary premature ovarian failure

A

Surgical menopause
Chemo or radiotherapy
Infectiosn (TB, mumps, malaria, varicella)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Endocrine changes in menopause

A

First change: fall in inhibin production (responsible for FSH production inhibition) - increased FSH

Reduces oestradiol levels- eventually insufficient to stimulate endometrial proliferation = menopause
Further decline in subsequent years - effects on all oestrogen-responsive tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

GU effects of menopause

A

Vaginal atrophy - trauma, dryness, spontaneous bleeding, infection
Distal urethra + trigone bladder - similar atrophy - urinary symptoms without infection
Pelvic floor dysfunction - weakening of supporting ligaments and tissues - increased prolapse and stress incontinence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Osteoporosis mechanism in menopause

A

oestrogen = anti-resorptive agent on trabecular bone

Thus, dec. oestrogen - inc. bone resorption - dec. bone density

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Oestrogen effects on CVS

A

inc. LDL, dec. HDL
direct effect on vessel wall - vasodilation via NO
thus increased risk of CVD after menopause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Short-term symptoms of menopause (0-5y)

A

Vasomotor: hot flushes, night sweats
Psychological: labile mood, anxiety, tearfulness
Cognitive: loss of concentration, poor memory
Joint aches and pains
Dry, itchy skin
Hair changes
Reduced libido

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Intermediate effects of menopause (3-10 years)

A
vaginal dryness, soreness
Dyspareunia
Sensory urgency
Urinary frequency
Recurrent UTIs
Urogenital prolapse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Long term effects of menopause (over 10y)

A

Osteoporosis
Cardiovascular disease
Dementia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Assessment of menopause:

A

frequency, severity and types of symptoms and impact on daily life
for most women, menopausal symptoms are relatively short lived and will settle within a few years
use as opportunity to raise awareness and practice preventative medicine

17
Q

lifestyle management of menopause

A

Smoking cessation
Optimise diet
Regular, low-intensity exercise
Minimise weight gain (average weight gain of 1kg/year around menopause)

18
Q

Alternative/complementary management of menopause

A

little is known about efficacy or safety:
Acupuncture, reflexology, magnetism
Herbal (black cohosh, evening primrose oil, st john’s wort, ginseng, ginko bilboa)
Bio-identical hormones (DHEA, natural progesterone gel, phytoestrogens - isoflavones, red clover)

19
Q

Non-hormonal pharmaceutical management options for menopause

A

SSRIs and gabapentin:

  • reduce hot flushes in short term
  • significant side effect profile

Alpha-adrenergic agnoists (Clonidine)

  • reduces hot flushes
  • far less effective than HRT
20
Q

Hormones to be given in HRT for menopause

A

Oestrogen - can only be given alone if no uterus is remaining (otherwise risk of endometrial cancer) + progesterone if uterus present
testosterone if surgical/chemo induced menopause

21
Q

Time frame of HRT

A

Minimal effective dose for shortest duration
Ideally should be discontinued by 5 years
average woman will need symptomatic relief for 2-3 years

22
Q

Routes of oestrogen administration

A

Oral - oestrone released into circulation, less expensive
Transdermal: avoids first-pass effect, reduced impact on haemostasis and coagulation (therefore better option in VTE/liver abnormalities)
+ more physiological (oestradiol released into circulation), logistically difficult to coadminister progesterone in unhysterectomised patients

23
Q

Side effects related to oestrogen

A
fluid retention
Nausea
Headaches
Breast enlargement
Leg cramps
Dyspepsia

Tend to settle within a few weeks

24
Q

Progesterone addition in HRT

A

added for 10 days per calendar month (mimic menstrual cycle)
Cyclical regimen for perimenopauseal women
Continuous for post-menopausal women (no bleeding)

25
Side effects related to progestogens
``` Fluid retention Breast tenderness Headaches Acne Mood swings Depression Irritability Bloating Constipation Increased appetite ``` usually more trouble-some than oestrogen related side effects, especially in first few months Switching dose or type of progestogen or to Mirena IUD may help
26
Symptoms of testosterone deficiency in a female
Loss of libido Decreased sexual activity Fatigue Reduced feeling of physical well-being
27
Breast cancer risk with HRT
increases risk by 4 in 1000 (usually 15/1000) No increase in risk if used for less than 5 years more associated with progesterone than oestrogen
28
Endometrial cancer risk with HRT
only in unopposed oestrogen if woman still has uterus | Therefore always use progesterone unless no uterus
29
VTE risk with HRT
Increases risk 2- fold (overall impact small given that background risk is low) - significantly increased risk in smokers, obese, underlying thrombophilia or history of VTE Highest risk in first year of use
30
Absolute contraindications to HRT
``` Suspected pregnancy Breast cancer Endometrial cancer Active liver disease Uncontrolled HTN Known VTE Known thrombophilia Otosclerosis ```
31
relative contraindications to HRT
``` Uninvestigated abnormal bleeding Large uterine fibroids Past history of benign breast disease Unconfirmed personal history or strong family history of VTE Chronic stable liver disease Migraine with aura ```
32
Benefits of HRT
Most effective therapy for perimenopausal symptoms (vasomotor, urogenital, sexual function) Treatment of osteoporosis Reduced risk of ?CVD, colon cancer
33
Vaginal oestrogen
safe for those contraindicated for systemic HRT useful only for urogenital symptoms progesterone not required daily for 2 weeks, then 1-2 times weekly for 12 months
34
Expected time for HRT to improve hot flush symptoms
4-6 weeks of treatment
35
Production of testosterone in women and effect of menopause
50% occurs in ovaries other 50% in adrenals and adipose Production not generally affected by natural menopause, but may become deficient if chemoradiation or surgical induced menopause
36
Regimens of HRT
Oestrogen only - post-hysterectomy Cyclical progesterone + oestrogen - perimenopausal women (still will have period) Continuous progesterone + oestrogen - postmenopausal women (will not have bleeding)